Silverarc Capital Management as of Sept. 30, 2024
Portfolio Holdings for Silverarc Capital Management
Silverarc Capital Management holds 69 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nuvalent Inc-a (NUVL) | 8.5 | $38M | 371k | 102.30 | |
| Merus N V (MRUS) | 7.1 | $32M | 635k | 49.96 | |
| Insmed Com Par $.01 (INSM) | 5.7 | $25M | 348k | 73.00 | |
| Avidity Biosciences Ord (RNA) | 4.9 | $22M | 476k | 45.93 | |
| Erasca (ERAS) | 4.3 | $19M | 6.9M | 2.73 | |
| Akero Therapeutics (AKRO) | 4.1 | $18M | 640k | 28.69 | |
| Veracyte (VCYT) | 3.6 | $16M | 471k | 34.04 | |
| Rhythm Pharmaceuticals (RYTM) | 3.0 | $13M | 256k | 52.39 | |
| Cogent Biosciences (COGT) | 3.0 | $13M | 1.2M | 10.80 | |
| Intra Cellular Therapies (ITCI) | 2.7 | $12M | 167k | 73.17 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 2.7 | $12M | 745k | 15.99 | |
| Urogen Pharma (URGN) | 2.6 | $11M | 901k | 12.70 | |
| Oric Pharmaceuticals (ORIC) | 2.5 | $11M | 1.1M | 10.25 | |
| Poseida Therapeutics I (PSTX) | 2.4 | $11M | 3.7M | 2.86 | |
| Verona Pharma Sponsored Ads (VRNA) | 2.3 | $10M | 349k | 28.77 | |
| Alnylam Pharmaceuticals (ALNY) | 2.2 | $9.8M | 36k | 275.03 | |
| Geron Corporation (GERN) | 1.8 | $8.2M | 1.8M | 4.54 | |
| C4 Therapeutics Com Stk (CCCC) | 1.7 | $7.4M | 1.3M | 5.70 | |
| Syndax Pharmaceuticals (SNDX) | 1.6 | $7.3M | 379k | 19.25 | |
| Vaxcyte (PCVX) | 1.6 | $6.9M | 61k | 114.27 | |
| Kalvista Pharmaceuticals (KALV) | 1.5 | $6.7M | 575k | 11.58 | |
| Protagonist Therapeutics (PTGX) | 1.5 | $6.6M | 147k | 45.00 | |
| Sarepta Therapeutics (SRPT) | 1.4 | $6.4M | 51k | 124.89 | |
| Biodesix | 1.4 | $6.3M | 3.6M | 1.78 | |
| Elutia Cl A Com (ELUT) | 1.4 | $6.3M | 1.6M | 3.81 | |
| Adc Therapeutics Sa SHS (ADCT) | 1.3 | $5.7M | 1.8M | 3.15 | |
| Gossamer Bio (GOSS) | 1.3 | $5.6M | 5.6M | 0.99 | |
| Olema Pharmaceuticals (OLMA) | 1.2 | $5.4M | 455k | 11.94 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 1.2 | $5.4M | 513k | 10.45 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.2 | $5.3M | 462k | 11.52 | |
| Wave Life Sciences SHS (WVE) | 1.2 | $5.1M | 628k | 8.20 | |
| Disc Medicine (IRON) | 1.1 | $5.1M | 104k | 49.14 | |
| Biohaven (BHVN) | 1.1 | $5.0M | 100k | 49.97 | |
| Celldex Therapeutics Com New (CLDX) | 1.1 | $4.9M | 145k | 33.99 | |
| Longboard Pharmaceuticals In | 0.9 | $4.1M | 124k | 33.33 | |
| Biogen Idec (BIIB) | 0.9 | $3.9M | 20k | 193.84 | |
| Praxis Precision Medicines I Com New (PRAX) | 0.9 | $3.9M | 67k | 57.54 | |
| Mersana Therapeutics | 0.7 | $3.3M | 1.8M | 1.89 | |
| Modular Med Com New (MODD) | 0.7 | $3.2M | 1.4M | 2.25 | |
| Solid Biosciences Com New (SLDB) | 0.7 | $3.2M | 458k | 6.97 | |
| Biontech Se Sponsored Ads (BNTX) | 0.7 | $3.1M | 26k | 118.77 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.7 | $3.1M | 71k | 43.89 | |
| Relay Therapeutics (RLAY) | 0.7 | $3.0M | 419k | 7.08 | |
| Tela Bio (TELA) | 0.6 | $2.8M | 1.1M | 2.53 | |
| Compugen Ord (CGEN) | 0.6 | $2.7M | 1.5M | 1.81 | |
| Cerus Corporation (CERS) | 0.6 | $2.6M | 1.5M | 1.74 | |
| Zevra Therapeutics Com New (ZVRA) | 0.5 | $2.4M | 350k | 6.94 | |
| Perspective Therapeutics Com New (CATX) | 0.5 | $2.2M | 168k | 13.35 | |
| Bioage Labs (BIOA) | 0.5 | $2.1M | 100k | 20.80 | |
| Unicycive Therapeutics | 0.4 | $1.6M | 4.0M | 0.41 | |
| Trevi Therapeutics (TRVI) | 0.4 | $1.6M | 483k | 3.34 | |
| Xencor (XNCR) | 0.3 | $1.5M | 76k | 20.11 | |
| Tarsus Pharmaceuticals (TARS) | 0.3 | $1.3M | 40k | 32.89 | |
| Kodiak Sciences (KOD) | 0.3 | $1.3M | 500k | 2.61 | |
| Evogene Shs New (EVGN) | 0.2 | $946k | 308k | 3.07 | |
| Molecular Templates Com New (MTEMQ) | 0.2 | $877k | 624k | 1.41 | |
| Applied Therapeutics | 0.2 | $850k | 100k | 8.50 | |
| Vaxart Com New (VXRT) | 0.2 | $849k | 1.0M | 0.85 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.2 | $799k | 100k | 7.99 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.2 | $747k | 5.0k | 149.31 | |
| Instil Bio Com New (TIL) | 0.2 | $708k | 11k | 67.32 | |
| 89bio (ETNB) | 0.2 | $683k | 92k | 7.40 | |
| Karyopharm Therapeutics | 0.1 | $464k | 559k | 0.83 | |
| Black Diamond Therapeutics (BDTX) | 0.1 | $435k | 100k | 4.35 | |
| Fractyl Health (GUTS) | 0.1 | $422k | 167k | 2.53 | |
| Corbus Pharmaceuticals Hldgs Call Call Option (CRBP) | 0.1 | $367k | 18k | 20.63 | |
| Aligos Therapeutics Com New (ALGS) | 0.1 | $227k | 26k | 8.66 | |
| Vyne Therapeutics (VYNE) | 0.0 | $144k | 77k | 1.88 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $6.8k | 105k | 0.06 |